Screener
Kestra Medical Technologies KMTS Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:ReceivablesNetCurrent.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
| Line item | April 30, 2026 | April 30, 2025 |
|---|---|---|
| Current assets | ||
| Cash and cash equivalents | $99,710 | $237,595 |
| Short-term investments | 96,724 | — |
| Accounts receivable, net | 14,542 | 8,081 |
| Disposable medical equipment supplies | 6,706 | 6,572 |
| Prepaid expenses and other current assets | 4,677 | 3,080 |
| Total current assets | 222,359 | 255,328 |
| Long-term investments | 65,767 | — |
Item 16. Form 10-K Summary.
FAQ
- What is Kestra Medical Technologies's accounts receivable?
- Kestra Medical Technologies (KMTS) reported accounts receivable of $14.54M in Q1 2026.
- How has Kestra Medical Technologies's accounts receivable changed year-over-year?
- Kestra Medical Technologies's accounts receivable increased by 80.0% year-over-year, from $8.08M to $14.54M.
- What is the long-term trend for Kestra Medical Technologies's accounts receivable?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's accounts receivable has grown at a 248.1% compound annual growth rate (CAGR), from $3.87M to $46.91M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about Kestra Medical Technologies's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude